ELIZABETH TISDALE: Open Payments
NPI 1477561785 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 30 payments from 9 companies in 2025. Trend: 2023 $284 · 2024 $613 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $183 |
| Galderma Laboratories, L.P. | 5 | $151 |
| ABBVIE INC. | 4 | $112 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| UCB, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, Sotyktu, Rhapsido, Bimzelx, ADBRY, RINVOQ.
Industry payments across NC — which companies pay providers there.
